GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (TSXV:AQS) » Definitions » Market Cap

Aequus Pharmaceuticals (TSXV:AQS) Market Cap : C$3.32 Mil (As of Jun. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aequus Pharmaceuticals's share price for the quarter that ended in Mar. 2024 was C$0.01. Aequus Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 132.63 Mil. Therefore, Aequus Pharmaceuticals's market cap for the quarter that ended in Mar. 2024 was C$1.33 Mil.

Aequus Pharmaceuticals's quarterly market cap declined from Sep. 2023 (C$4.64 Mil) to Dec. 2023 (C$3.32 Mil) and declined from Dec. 2023 (C$3.32 Mil) to Mar. 2024 (C$1.33 Mil).

Aequus Pharmaceuticals's annual market cap declined from Dec. 2021 (C$15.25 Mil) to Dec. 2022 (C$4.64 Mil) and declined from Dec. 2022 (C$4.64 Mil) to Dec. 2023 (C$3.32 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aequus Pharmaceuticals's Enterprise Value for Today is C$8.75 Mil.


Aequus Pharmaceuticals Market Cap Historical Data

The historical data trend for Aequus Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Market Cap Chart

Aequus Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.46 13.43 15.25 4.64 3.32

Aequus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.64 3.32 4.64 3.32 1.33

Competitive Comparison of Aequus Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aequus Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's Market Cap falls into.



Aequus Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aequus Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=C$0.025*132.634
=C$3.32

Aequus Pharmaceuticals's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=C$0.01*132.634
=C$1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aequus Pharmaceuticals  (TSXV:AQS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Aequus Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Aequus Pharmaceuticals (TSXV:AQS) Business Description

Traded in Other Exchanges
Address
200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
Executives
Doug Janzen Director, Senior Officer

Aequus Pharmaceuticals (TSXV:AQS) Headlines

No Headlines